Corteva, Inc. $CTVA Shares Acquired by Corient Private Wealth LLC

Corient Private Wealth LLC grew its position in shares of Corteva, Inc. (NYSE:CTVA) by 3.5% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund owned 201,416 shares of the company’s stock after purchasing an additional 6,854 shares during the quarter. Corient Private Wealth LLC’s holdings in Corteva were worth $13,505,000 as of its most recent filing with the SEC.

Other large investors have also recently bought and sold shares of the company. Vanguard Group Inc. boosted its stake in shares of Corteva by 0.4% during the fourth quarter. Vanguard Group Inc. now owns 80,536,951 shares of the company’s stock worth $5,398,392,000 after buying an additional 317,538 shares during the period. State Street Corp grew its stake in shares of Corteva by 3.7% during the 4th quarter. State Street Corp now owns 36,570,876 shares of the company’s stock worth $2,451,346,000 after purchasing an additional 1,290,071 shares during the period. Franklin Resources Inc. lifted its position in shares of Corteva by 4.3% during the 4th quarter. Franklin Resources Inc. now owns 19,537,500 shares of the company’s stock valued at $1,309,599,000 after acquiring an additional 805,873 shares during the period. Harris Associates L P boosted its position in Corteva by 168.1% during the fourth quarter. Harris Associates L P now owns 17,026,221 shares of the company’s stock worth $1,141,268,000 after purchasing an additional 10,675,052 shares in the last quarter. Finally, Northern Trust Corp boosted its position in shares of Corteva by 5.0% in the 4th quarter. Northern Trust Corp now owns 11,731,834 shares of the company’s stock worth $786,385,000 after buying an additional 562,550 shares in the last quarter. Institutional investors and hedge funds own 81.54% of the company’s stock.

Corteva Price Performance

CTVA opened at $79.36 on Wednesday. The firm has a market cap of $53.08 billion, a price-to-earnings ratio of 46.68, a price-to-earnings-growth ratio of 2.41 and a beta of 0.57. Corteva, Inc. has a fifty-two week low of $60.53 and a fifty-two week high of $85.63. The company has a quick ratio of 1.03, a current ratio of 1.47 and a debt-to-equity ratio of 0.07. The company’s 50-day moving average price is $79.45 and its 200 day moving average price is $75.95.

Corteva (NYSE:CTVA) last released its quarterly earnings data on Tuesday, May 5th. The company reported $1.50 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.18 by $0.32. Corteva had a return on equity of 9.95% and a net margin of 6.50%.The business had revenue of $4.91 billion during the quarter, compared to analyst estimates of $4.64 billion. During the same quarter in the previous year, the firm posted $1.13 EPS. The business’s revenue for the quarter was up 11.0% compared to the same quarter last year. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. As a group, sell-side analysts expect that Corteva, Inc. will post 3.72 earnings per share for the current year.

Corteva Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Monday, June 15th. Stockholders of record on Monday, June 1st were given a dividend of $0.18 per share. The ex-dividend date was Monday, June 1st. This represents a $0.72 annualized dividend and a dividend yield of 0.9%. Corteva’s payout ratio is currently 42.35%.

Analyst Ratings Changes

CTVA has been the subject of several recent research reports. BNP Paribas Exane raised their price target on Corteva from $74.00 to $77.00 in a research report on Wednesday, May 6th. Morgan Stanley boosted their price objective on shares of Corteva from $84.00 to $95.00 and gave the company an “overweight” rating in a research note on Thursday, May 28th. The Goldman Sachs Group lifted their price target on shares of Corteva from $88.00 to $96.00 and gave the company a “buy” rating in a research report on Tuesday, April 14th. Barclays boosted their price objective on Corteva from $84.00 to $91.00 and gave the stock an “overweight” rating in a research note on Thursday, June 11th. Finally, Royal Bank Of Canada raised their price target on shares of Corteva from $95.00 to $97.00 and gave the company an “outperform” rating in a report on Thursday, May 7th. Fourteen research analysts have rated the stock with a Buy rating and nine have given a Hold rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average target price of $88.81.

Corteva Company Profile

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.